Literature DB >> 6809805

Iodine contamination as a cause of hyperthyroidism or lack of TSH response to TRH stimulation (results based on a screening investigation).

J Habermann, B Leisner, A Witte, C R Pickardt, P C Scriba.   

Abstract

The sera of all patients with completely suppressed TSH response to TRH obtained during one year (n = 668), and of those with diminished TSH response (n = 153) were screened for total serum iodine content. The ratio between serum iodine and thyroxine iodine below 1.5 indicates none or only a minor degree of iodine contamination, whereas a ratio above 1.5 is a clear index of exogenous iodine contamination. Eighty-four (21.3%) of 395 patients with overt hyperthyroidism were iodine contaminated. No prevalence of hyperthyroidism with hyperthyroxinemia could be detected as compared to T3-hyperthyroidism in the contaminated groups. Surprisingly, the iodine contamination rate was twice as high in 273 patients with suppressed TSH response to TRH but normal thyroid hormone levels and not fully explained thyroidal diseases. A high incidence of multifocal autonomous adenomas of the thyroid is the most probable explanation for the TSH suppression in iodine contaminated patients with normal thyroid hormone levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809805     DOI: 10.1007/BF03349470

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  [Thyroidal autoregulation in nontoxic goiter patients: normalization of the T3/T4 ratio in serum by treatment with potassium iodide (author's transl)].

Authors:  K Horn; D Koeppen; C R Pickardt; P C Scriba
Journal:  Klin Wochenschr       Date:  1975-01-15

2.  Modifications of thyroid function induced by chronic administration of iodide in the presence of "autonomous" thyroid tissue.

Authors:  A M Ermans; M Camus
Journal:  Acta Endocrinol (Copenh)       Date:  1972-07

3.  [Improvement and quality control of the radioimmunological TSH determination (author's transl)].

Authors:  F Erhardt; I Marschner; R C Pickardt; P C Scriba
Journal:  Z Klin Chem Klin Biochem       Date:  1973-09

4.  [Decompensation of autonomous thyroid adenoma after long-term iodine intake (author's transl)].

Authors:  J Mahlstedt; K Joseph
Journal:  Dtsch Med Wochenschr       Date:  1973-09-21       Impact factor: 0.628

5.  The autonomous functioning thyroid nodule in the evolution of nodular goiter.

Authors:  J M Miller; R C Horn; M A Block
Journal:  J Clin Endocrinol Metab       Date:  1967-09       Impact factor: 5.958

6.  Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents.

Authors:  H Bürgi; C Wimpfheimer; A Burger; W Zaunbauer; H Rösler; T Lemarchand-Béraud
Journal:  J Clin Endocrinol Metab       Date:  1976-12       Impact factor: 5.958

7.  [Alimentary iodine deficiency in the Federal Republic of Germany (author's transl)].

Authors:  J Habermann; H G Heinze; K Horn; R Kantlehner; I Marschner; J Neumann; P Scriba
Journal:  Dtsch Med Wochenschr       Date:  1975-09-26       Impact factor: 0.628

8.  [Incidence of goiter and tracheal constriction among outpatients of a Munich hospital (author's transl)].

Authors:  K W Frey; M Englestädter
Journal:  MMW Munch Med Wochenschr       Date:  1976-11-26

9.  Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters.

Authors:  H Studer; H R Hunziker; C Ruchti
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

10.  [The treatment of arrhythmias with amiodarone].

Authors:  M Stäubli; H Studer
Journal:  Schweiz Med Wochenschr       Date:  1981-03-28
View more
  2 in total

1.  [Operative indications and surgical procedure in iodine-induced hyperthyroidism].

Authors:  H Dralle; W Lang; D P Pretschner; R Pichlmayr; R D Hesch
Journal:  Langenbecks Arch Chir       Date:  1985

2.  TRH: pathophysiologic and clinical implications.

Authors:  C R Pickardt; P C Scriba
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.